Endurant Capital Management LP Jazz Pharmaceuticals PLC Transaction History

Endurant Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $425,963 - $612,602	-3,674 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $591,550 - $663,414	3,674 New	3,674 $618,000
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $746,283 - $934,218	-5,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $20,338 - $23,574	150 Added 3.03%	5,100 $770,000
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $1.77 Million - $2.03 Million	-13,500 Reduced 73.17%	4,950 $667,000
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $2.63 Million - $2.87 Million	18,450	18,450 $2.7 Million

516

57.8M

188K

110K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.54B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.